Latest News
Benz Announces Results of Special Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - August 17, 2026) - Benz Mining Corp (ASX: BNZ) (TSXV: BZ) ("Benz" or the "Company") is pleased to announce the results of voting at its Special Meeting o
ROSEN, LEADING TRIAL COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PH
Neurothera Labs Inc. Closes Final Tranche of Non-Brokered Private Placement
T oronto, Ontario – TheNewswire - August 17, 2026 – NeuroThera Labs Inc. (the “ Company ” or “ NeuroThera ”) (TSXV: NTLX), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc
PLNT DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Planet Fitness, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLNT
New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Planet Fitness, Inc. (NYSE: PLNT) between Novembe
Insulet Deadline: PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit
NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26,
Yalla Group Q2 Earnings Call Highlights
Yalla Group NYSE: YALA reported second-quarter 2026 revenue of $82.6 million, exceeding the upper end of its prior guidance, as growth in game services and a recovery in flagship products helped offse
Atlassian Conference Highlights AI-Led Cloud Growth, Expanding Enterprise Demand
Atlassian NASDAQ: TEAM said its cloud business momentum continued through the fourth quarter of fiscal 2026, supported by customer upgrades, cross-selling activity and expanding paid seats across both
2 WEEK INVESTOR DEADLINE: Insulet Corporation Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 Deadline - PODD
SAN DIEGO, Aug. 17, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26,
Vector Limited (VETTF) Q4 2026 Earnings Call Transcript
Vector Limited (VETTF) Q4 2026 Earnings Call Transcript
How an AirTag planted by a reporter led to a secret Amazon site where old books are cut apart and scanned
404 Media put an Apple AirTag in a rare book and tracked it to an Amazon warehouse in Las Vegas, where a team cuts the bindings off books and scans the pages.
CyberCatch Announces Signing of Definitive Agreement for Datavault AI to Acquire the Company in All-Cash Transaction
Vancouver, British Columbia and San Diego, California--(Newsfile Corp. - August 17, 2026) - CyberCatch Holdings, Inc. (TSXV: CYBE) (OTCQB: CYBHF), a cybersecurity company offering a patented, AI-enabl
WIX INVESTOR ALERT: Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead the Wix Class Action Lawsuit - September 22, 2026 Deadline
San Diego, California--(Newsfile Corp. - August 17, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Wix.com Ltd. (NASDAQ: WIX) securities between February 19, 2025 a
BZAI CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Blaize Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blaize To Contact Him Directly To Discuss Their Options If you purchased or acquired
Argo Graphene Solutions Announces $1 Million Financing to Advance STREAM(TM) Graphene Refinery Strategy and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 17, 2026) - Argo Graphene Solutions Corp. (CSE: ARGO) (OTCQB: ARLSF) (FSE: 94Y) ("Argo" or the "Company") is pleased to announce a proposed non-br
BE CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Bloom Energy (BE) Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bloom Energy To Contact Him Directly To Discuss Their Options If you purchased or acq
Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TB
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Smartsheet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMAR
New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Smartsheet Inc. (NYSE: SMAR) between June 1, 2024 an
GTM CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ZoomInfo Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ZoomInfo To Contact Him Directly To Discuss Their Options If you purchased or acquire
REGN CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly To Discuss Their Options If you purchased or acquir
Stoke Therapeutics' Dravet Trial Tops Enrollment Target With Zero Dropouts
Stoke Therapeutics NASDAQ: STOK said its Phase III EMPEROR study of zorevunersen for Dravet syndrome has enrolled 162 patients, exceeding its target enrollment of 150, with no patient discontinuations